MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Leucine-rich repeat kinase 2(LRRK2)"

  • 2022 International Congress

    Mutational effects of LRRK2 I1371V in astrocytes derived from patient specific iPSCs

    R. Banerjee, I. Datta, S. Jagtap, A. Raj (Bangalore, India)

    Objective: To identify the LRRK2 I1371V mutational effects on astroglial biology involving glutamate metabolism and glutathione machinery. Background: The underlying cause of most of the familial…
  • 2022 International Congress

    Identification and functional characterization of genetic modifier of penetrance in G2019S LRRK2-associated Parkinson’s disease through family whole genome sequencing

    J. Ohnmacht, D. Bobbili, P. May, E. Glaab, J. Kaye, S. Finkbeiner, R. Krüger (Strassen, Luxembourg)

    Objective: Trait- or disease-associated genetic variants contribute to substantial variability and penetrance of complex traits and diseases in humans. Several causative genes and risk factors…
  • 2022 International Congress

    Evaluation of α-synuclein pathology and function in dopaminergic neurons derived from LRRK2 I1371V PD patient iPSCs

    I. Datta, S. Jagtap, C. Potdar (Bangalore, India)

    Objective: To evaluate cellular pathogenesis in DA neuron function, and α-synuclein pathology using LRRK2-I1371V PD iPSC. Background: It is reported for complex-neurodegenerative disorders like PD,…
  • 2022 International Congress

    Sensor-based gait analysis in the premotor stage of LRRK2 G2019S-associated Parkinson’s disease

    A. Sánchez Rodríguez, C. Tirnauca, D. Salas-Gómez, M. Fernández-Gorgojo, I. Martínez Rodríguez, M. Sierra, I. González Aramburu, D. Stan, A. Gutierrez-González, J. M Meissner, J. Andrés Pacheco, M. Rivera Sánchez, M. Sánchez-Peláez, P. Sánchez Juan, J. Infante (Santander, Spain)

    Objective: To evaluate in a group of asymptomatic carriers of the G2019S mutation of the LRRK2 gene if there are subclinical gait alterations, detectable with…
  • 2022 International Congress

    The influence of GBA and LRRK2 on mood disorders in Parkinson’s Disease

    A. Thaler, N. Omer, B. Cohen, N. Giladi, M. Kestenbaum, J. Shirvan, J. Cedarbaum, M. Gana-Weisz, O. Goldstein, A. Orr-Urtreger, A. Mirelman (Tel-Aviv, Israel)

    Objective: To assess the influence of mutations in the LRRK2 and GBA genes on mood disorders among patients with Parkinson's disease (PD) Background: Mood disorders…
  • 2022 International Congress

    Genetics Of Parkinson’s in India – Young Onset Parkinson’s Disease (GOPI-YOPD) : Genetics of Juvenile, Young and Early Onset Parkinson’s Disease

    P. Kukkle, V. Goyal, T. Geetha, R. Menon, R. Kandadai, U. Mahadevia, H. Kumar, R. Borgohain, A. Mukherjee, P. Wadia, R. Yadav, S. Desai, N. Kumar, S. Nair, S. Murugan, A. Biswas, P. Pal, M. Oliver, S. Sundaram, M. Deshmukh, A. Bassi, C. Sandeep, N. Mandloi, A. Kayalvizhi, U. Muthane, S. Das, S. Seshagiri, R. Gupta, V. Ramprasad (Bangalore, India)

    Objective: To determine the genetic and demographic patterns of juvenile-onset (JOPD, <20 years), young-onset (YOPD, 20-40 years), and early onset (EOPD, 40-50 years) Parkinson's disease…
  • 2022 International Congress

    Clinical phenotype of non-manifesting carriers of mutations in the GBA and LRRK2 genes

    N. Omer, N. Giladi, A. Bar-Shira, M. Gana-Weisz, O. Goldstein, O. Asias, J. Shirvan, J. Cedarbaum, M. Kestenbaum, A. Orr-Urtreger, R. Alcalay, A. Mirelman, A. Thaler (Tel-Aviv, Israel)

    Objective: To explore the influence of carrying mutations in both the GBA and LRRK2 genes (dual mutation carriers) on risk for future development of Parkinson's…
  • 2022 International Congress

    Patterns of TDP-43 Deposition in Brains with LRRK2 G2019S Mutations

    J. Agin-Liebes, R. Hickman, J. Vonsattel, X. Flowers, P. Faust, R. Mayeux, K. Marder, S. Przedborski, S. Fahn, M. Surface, R. Alcalay (New York, USA)

    Objective: To systematically examine the Columbia University LRRK2 brain bank for TDP-43 deposits Background: LRRK2 G2019S mutations have been associated with parkinsonism and a wide range of…
  • 2022 International Congress

    The mitochondrial risk score and lifestyle factors are associated with age at onset in LRRK2 p.Gly2019Ser Parkinson’s disease.

    T. Lüth, C. Gabbert, P. Lajer, I. König, A. Caliebe, S. Koch, B-H. Laabs, F. Hentati, S. Sassi, R. Amouri, C. Klein, A. Grünewald, M. Farrer, J. Trinh (Lübeck, Germany)

    Objective: To investigate the relationship between a mitochondrial risk score (MRS), lifestyle and age at onset (AAO) in LRRK2 G2019S Parkinson’s disease (PD). Background: PD…
  • 2022 International Congress

    A case with clinical features of alpha-synuclein- and tauopathy: Genetic and histopathological workup.

    D. Gruber, C. Mawrin, A. Vogel, T. Usnich, N. Brueggemann, C. Klein, P. Bauer, F. Gandor, G. Ebersbach (Beelitz-Heilstaetten, Germany)

    Objective: Here, we present a clinical case that mimicked the coincidence of idiopathic Parkinson’s disease (PD) and tauopathy. Background: Mutation in leucine-rich-repeat-kinase 2 (LRRK2) gene…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 21
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley